MedTrace Logo

Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.

NCT02333448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-02-20

No results posted yet for this study

Summary

The study consists in taking 4 tubes of blood at different times over a period of 10 days, via a catheter (central venous or arterial catheter) already in place in the usual therapeutic management. These samples will make it possible to measure blood levels of certain markers specific to invasive candidiasis. PCR will be used to quantify fungal load precisely, that is to say the quantity of yeast present in the blood and to monitor this quantity over time.

These samples will be transferred to a specialized unit and stored for a maximum of three years for use at the end of the study.

Conditions

  • Invasive Candidiasis; Treatment With Echinocandin

Interventions

BIOLOGICAL

Blood sample taken on the day the treatment is initiated

BIOLOGICAL

Blood sample taken on day 3 after initiation of treatment

BIOLOGICAL

Blood sample taken on day 5 after initiation of

BIOLOGICAL

Blood sample taken on day 7 after initiation of treatment

BIOLOGICAL

Blood sample taken on day 10 after initiation of treatment

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-12
Primary Completion
2019-09-17
Completion
2019-09-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333448 on ClinicalTrials.gov